medical credentials have passed the annual screening by the researcher staff of Castle Connolly Medical Ltd, publishers of
America's Top Doctors. Dr. Alfred Rosenbaum's records were vetted for:
• state licensing,
• board certification,
• licensing and/or other disciplinary action as available from public sources.
Castle Connolly Medical Ltd. - the trusted source for quality health healthcare choices
If you’re a Westchester resident with prostate cancer then IMRT should be your treatment choice. Bronx based radiation oncologist Dr. Alfred Rosenbaum is at the forefront of prostate cancer treatment through the use of cutting edge Intensity Modulated Radiation Therapy (IMRT).
Prostate cancer is a leading cause of cancer death in American men and the American Cancer Society estimates that 27,000 men in the United States die of prostate cancer each year. Dr Rosenbaum's goal is to lead the battle to reduce this statistic by early and effective treatment, including IMRT and outpatient Brachytherapy (seed implantation).
IMRT is made possible due to the use of sophisticated computers. Each treatment is specifically tailored to the individual patient, depending upon the extent and nature of the prostate cancer present. Using a CT and MRI, Dr. Rosenbaum programs the computer with the information regarding how much radiation to give the prostate and the surrounding tissues. The computer determines the best way to deliver the treatment by varying, or "modulating," the intensity of each radiation beam.
If you or someone you know suffers from prostate cancer then call Dr. Rosenbaum and see if IMRT can help in the treatment of prostate cancer.
This office serves patients in the following areas:
Pelham, Pelham Manor, Baychester, Eastchester Bronx, West Farms, University Heights, Morris Heights, City Island, Melrose, Hunts Point, Port Morris, Mott Haven, Harlem, Morris Heights, Inwood, Lincoln, Ludlow, Park Hill, Mount Vernon, New Rochelle, Bronx, New York City, NY 10469
Prostate Cancer Treatment, Dr. Alfred Rosenbaum,
The Eastchester Center for Cancer Care
